Results 131 to 140 of about 13,476,144 (183)

Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers. [PDF]

Biomed Res Int, 2013
Khlifi R, Messaoud O, Rebai A, Hamza-Chaffai A.   +3 more
europepmc   +1 more source

Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice. [PDF]

Proc Natl Acad Sci U S A, 2017
Camporez JP, Wang Y, Faarkrog K, Chukijrungroat N, Petersen KF, Shulman GI.   +5 more
europepmc   +1 more source

Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine. [PDF]

BMC Pharmacol Toxicol, 2014
Hou ZD, Xiao ZY, Gong Y, Zhang YP, Zeng QY.   +4 more
europepmc   +1 more source

Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer. [PDF]

BMC Cancer, 2014
Endo Y, Yamashita H, Takahashi S, Sato S, Yoshimoto N, Asano T, Hato Y, Dong Y, Fujii Y, Toyama T.   +9 more
europepmc   +1 more source

Impact of <i>N</i>-Acetylation on DNA Damage and Oxidative Stress Responses in Mammalian Cells and Human Hepatocytes Treated with Hydralazine. [PDF]

Biomolecules
Habil MR, Stephens MA, Cass AA, Mittlestat EM, Kwon D, Ellison A, Kouokam JC, Hein DW.   +7 more
europepmc   +1 more source

Genetic Landscape of NAT2 in the Moroccan Population: Implications for Isoniazid Pharmacogenetics in Tuberculosis. [PDF]

Clin Transl Sci
Benyahya N, El-Hamri MA, Lyahyai J, Ratbi I, Cherkaoui I, Rchiad Z, Sefiani A.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Arylamine N-acetyltransferase I

International Journal of Biochemistry and Cell Biology, 2007
Arylamine N-acetyltransferase I (NAT1) is a phase II enzyme that acetylates a wide range of arylamine and hydrazine substrates. The NAT1 gene is located on chromosome 8 and shares homology to NAT genes found in most mammalian species. Gene expression occurs from at least two promoters and a number of tissue-specific transcripts have been identified ...
Carston Wagner, Neville Butcher, Fernando Rodrigues Lima   +2 more
exaly   +6 more sources

Arylamine N-acetyltransferase in human red blood cells

Biochemical Pharmacology, 1992
N-Acetyltransferase activities associated with erythrocytes from 20 individuals have been determined with p-aminobenzoic acid as substrate. A three-fold variation in Vmax is found. The N-acetyltransferase genotype of the individuals has been determined and there is no correlation between the extent of acetylation measured in the individuals ...
Edith Sim, Alison Ward, D Hickman
exaly   +3 more sources

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2

Bioorganic and Medicinal Chemistry, 2009
The identification, synthesis and evaluation of a series of rhodanine and thiazolidin-2,4-dione derivatives as selective inhibitors of human arylamine N-acetyltransferase 1 and mouse arylamine N-acetyltransferase 2 is described.
Christina Redfield, Edith Sim, Edward Lowe   +2 more
exaly   +2 more sources

ArylamineN-acetyltransferases

Expert Opinion on Drug Metabolism & Toxicology, 2007
Arylamine N-acetyltransferases (NATs), known as drug- and carcinogen-metabolising enzymes, have had historic roles in cellular metabolism, carcinogenesis and pharmacogenetics, including epidemiological studies of disease susceptibility. NAT research in the past 5 years builds on that history and additionally paves the way for establishing the following
Edith, Sim, Isaac, Westwood, Elizabeth, Fullam   +2 more
openaire   +3 more sources